InsiderTrades.com logo
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

INDV Insider Trading

Insider Ownership Percentage: 0.67%
Insider Buying (Last 12 Months): £56,803
Insider Selling (Last 12 Months): GBX 0

Indivior Insider Trading History Chart

This chart shows the insider buying and selling history at Indivior by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Indivior Share Price & Price History

Current Price: GBX 1,192
Price Change: ▲ Price Increase of +12 (1.02%)
As of 12/8/2023 01:00 AM ET

This chart shows the closing price history over time for INDV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Indivior Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2023Graham HetheringtonInsiderBuy2,650GBX 1,350£35,775
3/6/2023Mark StejbachInsiderBuy1,400GBX 1,502£21,028
8/10/2021Mark StejbachInsiderBuy36,000GBX 162£58,320
8/6/2021Jerome LandeInsiderSell120,000GBX 163£195,600
8/4/2021Graham HetheringtonInsiderBuy29,220GBX 171£49,966.20
8/2/2021Jerome LandeInsiderSell184,219GBX 163£300,276.97
7/30/2021Jerome LandeInsiderSell271,349GBX 160£434,158.40
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Indivior (LON:INDV)

68.66% of Indivior stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Indivior logo
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Read More on Indivior

Today's Range

Now: GBX 1,192
Low: 1,171
High: 1,202

50 Day Range

MA: GBX 1,465.42
Low: 1,180
High: 1,731

52 Week Range

Now: GBX 1,192
Low: 1,156
High: 2,020

Volume

340,686 shs

Average Volume

376,749 shs

Market Capitalization

£1.64 billion

P/E Ratio

N/A

Dividend Yield

4.48%

Beta

N/A

Who are the company insiders with the largest holdings of Indivior?

Indivior's top insider shareholders include:
  1. Graham Hetherington (Insider)
  2. Mark Stejbach (Insider)
Learn More about top insider investors at Indivior.
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.